anmelden
25 € WM-Startbonus auf dein Cash-Konto
BX Swiss TOP 30 CHF
1.480,29
PKT
-6,17
PKT
-0,42
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 26.07.21 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 26.07.21 | UBS Buy | UBS AG | |
| 26.07.21 | UBS Equal-weight | Morgan Stanley | |
| 26.07.21 | Swiss Re Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 26.07.21 | Givaudan Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 23.07.21 | Roche Neutral | Credit Suisse Group | |
| 23.07.21 | Givaudan Buy | UBS AG | |
| 23.07.21 | Novartis Buy | UBS AG | |
| 23.07.21 | ABB (Asea Brown Boveri) Buy | UBS AG | |
| 23.07.21 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 23.07.21 | ABB (Asea Brown Boveri) Underweight | Morgan Stanley | |
| 23.07.21 | Givaudan Add | Baader Bank | |
| 23.07.21 | UBS Sector Perform | RBC Capital Markets | |
| 23.07.21 | ABB (Asea Brown Boveri) Equal Weight | Barclays Capital | |
| 22.07.21 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 22.07.21 | Novartis Hold | Deutsche Bank AG | |
| 22.07.21 | ABB (Asea Brown Boveri) Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 22.07.21 | Roche Neutral | UBS AG | |
| 22.07.21 | ABB (Asea Brown Boveri) Buy | UBS AG | |
| 22.07.21 | Novartis Neutral | Credit Suisse Group | |
| 22.07.21 | Givaudan Add | Baader Bank | |
| 22.07.21 | Roche Buy | Jefferies & Company Inc. | |
| 22.07.21 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 22.07.21 | Givaudan Underperform | Bernstein Research | |
| 22.07.21 | Roche Outperform | Bernstein Research | |
| 22.07.21 | Givaudan Neutral | Goldman Sachs Group Inc. | |
| 22.07.21 | Givaudan Underperform | Jefferies & Company Inc. | |
| 22.07.21 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 22.07.21 | ABB (Asea Brown Boveri) Underperform | Jefferies & Company Inc. | |
| 22.07.21 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 22.07.21 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 22.07.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.07.21 | Novartis Market-Perform | Bernstein Research | |
| 21.07.21 | Holcim Buy | Goldman Sachs Group Inc. | |
| 21.07.21 | Novartis Market-Perform | Bernstein Research | |
| 21.07.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 21.07.21 | UBS Outperform | Credit Suisse Group | |
| 21.07.21 | UBS Underweight | Barclays Capital | |
| 21.07.21 | Zurich Insurance Overweight | Morgan Stanley | |
| 21.07.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. |